Jusciele B Moreli1, Simone Corrêa-Silva2, Débora C Damasceno3, Yuri K Sinzato3, Aline R Lorenzon-Ojea4, Alexandre U Borbely4, Marilza V C Rudge3, Estela Bevilacqua4, Iracema M P Calderon5. 1. Post-graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, São Paulo State University, São Paulo, Brazil. Electronic address: juscielemoreli@gmail.com. 2. Post-graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, São Paulo State University, São Paulo, Brazil; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. 3. Post-graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, São Paulo State University, São Paulo, Brazil. 4. Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. 5. Post-graduate Program in Gynecology, Obstetrics and Mastology, Botucatu Medical School, São Paulo State University, São Paulo, Brazil. Electronic address: calderon@fmb.unesp.br.
Abstract
AIMS: TNF-α is a diabetogenic cytokine associated with adverse outcomes during pregnancy that can be counterbalanced by IL-10. We have investigated IL-10 and TNF-α balance at maternal and placental levels in hyperglycemia-associated pregnancies. METHODS: One hundred and ninety-two pregnant women participated, which included normoglycemic women (ND) and women with mild gestational hyperglycemia (MGH), gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM2). Maternal plasma and placental tissue IL-10 and TNF-α levels were measured by ELISA and placental TNF-α was also immunolocalized. RESULTS: Maternal plasma TNF-α levels were highest in GDM (p=0.0190), whereas TNF-α levels were highest in placental tissues in DM2 (p=0.0095). Immunohistochemistry also showed strong reactivity with anti-TNF-α antibody in the villous structures in the DM2 group. Conversely, IL-10 levels were lowest in maternal plasma of the DM2 group (p=0.0228). The TNF-α/IL-10 ratio in maternal plasma progressively increased with the severity of hyperglycemia (p<0.0001), being highest in placenta of the DM2 group (p=0.0150). In both, plasma and placenta, TNF-α/IL-10 ratio were correlated with mean maternal glycemia and HbA1c levels. CONCLUSIONS: Alterations of placenta and serum TNF-α/IL-10 balance with predominance of TNF-α were correlated with the severity of hyperglycemia during gestation. This association may offer insight into the pathogenesis of gestational hyperglycemia and associated pregnancy outcomes.
AIMS: TNF-α is a diabetogenic cytokine associated with adverse outcomes during pregnancy that can be counterbalanced by IL-10. We have investigated IL-10 and TNF-α balance at maternal and placental levels in hyperglycemia-associated pregnancies. METHODS: One hundred and ninety-two pregnant women participated, which included normoglycemic women (ND) and women with mild gestational hyperglycemia (MGH), gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM2). Maternal plasma and placental tissue IL-10 and TNF-α levels were measured by ELISA and placental TNF-α was also immunolocalized. RESULTS: Maternal plasma TNF-α levels were highest in GDM (p=0.0190), whereas TNF-α levels were highest in placental tissues in DM2 (p=0.0095). Immunohistochemistry also showed strong reactivity with anti-TNF-α antibody in the villous structures in the DM2 group. Conversely, IL-10 levels were lowest in maternal plasma of the DM2 group (p=0.0228). The TNF-α/IL-10 ratio in maternal plasma progressively increased with the severity of hyperglycemia (p<0.0001), being highest in placenta of the DM2 group (p=0.0150). In both, plasma and placenta, TNF-α/IL-10 ratio were correlated with mean maternal glycemia and HbA1c levels. CONCLUSIONS: Alterations of placenta and serum TNF-α/IL-10 balance with predominance of TNF-α were correlated with the severity of hyperglycemia during gestation. This association may offer insight into the pathogenesis of gestational hyperglycemia and associated pregnancy outcomes.
Authors: Aline M Thomas; Ying Dong; Nicholas M Beskid; Andrés J García; Andrew B Adams; Julia E Babensee Journal: J Cell Physiol Date: 2019-11-01 Impact factor: 6.384
Authors: Linda Englund-Ögge; Bryndis Eva Birgisdottir; Verena Sengpiel; Anne Lise Brantsæter; Margareta Haugen; Ronny Myhre; Helle Margrete Meltzer; Bo Jacobsson Journal: PLoS One Date: 2017-03-01 Impact factor: 3.240
Authors: Simon Keckstein; Sophia Pritz; Niklas Amann; Sarah Meister; Susanne Beyer; Magdalena Jegen; Christina Kuhn; Stefan Hutter; Julia Knabl; Sven Mahner; Thomas Kolben; Udo Jeschke; Theresa M Kolben Journal: Int J Mol Sci Date: 2020-10-28 Impact factor: 5.923